Navigation Links
Entrust Continues Leadership by Adding Support for Next-generation E-Passports
Date:10/1/2007

Advanced digital certificates help secure new biometrics to be stored on

next evolution of e-passports

DALLAS, Oct. 1 /PRNewswire-FirstCall/ -- Domestic and global security threats, coupled with rapidly emerging standards and technology, are leading governments across the world to pursue the issuance of more sophisticated machine readable travel documents (MRTDs) to their citizens. Entrust, Inc. (Nasdaq: ENTU), a leader in e-passport deployment and innovation, has announced the development of public key infrastructure (PKI) for the next generation of e-passport security, also known as Extended Access Control (EAC).

"Because we already help secure e-passports and national ID cards for governments around the world, it's only natural that Entrust plays a vital role in the development of this next level of e-passport technology," said Entrust Chairman, President and Chief Executive Officer Bill Conner. "As part of a layered security approach, Entrust PKI solutions help increase security, improve efficiency and promote cost-effectiveness to enable a more citizen-centric government."

EAC provides a higher level of security during the verification process of e-passports. Not based on the X.509 standard, EAC will leverage a new type of certificate established by the International Civil Aviation Organization (ICAO) known as a card verifiable (CV) certificate. Entrust is actively participating in the technical groups working on the new CV standard, including attending the Brussels Interoperability Group (BIG) meeting this week in Paris, France.

These next-generation e-passports will be required by all member European Union (EU) nations by June 2009. Deployment mandates for the U.S
'/>"/>

SOURCE Entrust, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Arctic coring expedition continues to yield new clues
2. Mine runoff continues to provide clues to microbial diversification
3. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
4. Adding radiation decreases breast cancer recurrence
5. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
6. Kinovate Life Sciences Launches Nittophase?High Performance Solid Support For Oligonucleatide Synthesis
7. Gene therapy promising for growing tooth-supporting bone
8. Cancer support cells may evolve, fuel tumor growth, study shows
9. New evidence supports century-old theory of cancer spread
10. Slow-frozen people? Latest research supports possibility of cyropreservation
11. Study supports urgent need for worldwide ban on lead-based paint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... June 30, 2015 ... the addition of the "Capacitive Fingerprint Sensors ... To this date, fingerprint sensing technology is ... fingerprint sensors are well developed. This patent landscape ... The domain of capacitive fingerprint sensors ...
(Date:7/2/2015)... , June 25, 2015 ... of the "Next Generation Biometrics Market by Application, ... report to their offering. The next ... by 2020, at a CAGR of 17.9% between 2015 ... leading application for the market. Safran SA ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Latin America Biomedical Sensors Market Report 2015-2020 2
... to as the land of opportunity. Faizan Naqvi, of ... NJIT gave him the opportunity, for instance, to work on ... the department of physics. Naqvi started the research when he ... helped him win a Goldwater Scholarship an award that ...
... cry for help with a device to diagnose dry eye, ... doesn,t produce enough tears or the tears evaporate too quickly. ... that controls the air around a patient,s eyes so doctors ... condition. Stephen Pflugfelder, the James and Margaret Elkins ...
... invertebrates living on the Port Valdez seafloor to stabilize ... scientist at the University of Alaska Fairbanks. "The ... the tsunami waves that followed, impacted every marine community ... assistant professor at the UAF School of Fisheries and ...
Cached Biology News:Third brother wins gold at NJIT 2Rice bioengineering students' invention may help diagnose painful eye condition 2Port Valdez invertebrates stabilized 26 years after quake 2
(Date:7/29/2015)... ... July 29, 2015 , ... G-CON Manufacturing, Inc., ... of their 2nd generation cell therapy POD® design. The 2nd generation portfolio not ... represents a new POD® design. , “G-CON first offered our miniPOD CT ...
(Date:7/29/2015)... 29, 2015  AmnioChor Inc., an early stage biotech ... pleased to announce that the Musculoskeletal Transplant Foundation of ... invest in their seed round of development of the ... capabilities. AmnioChor,s technology allows cryopreservation of ... stem cells living within those tissues. Amnion is a ...
(Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... has selected an optimized Erk inhibitor molecule for ... development of a new class of potential cancer ... a prime target for therapeutic intervention in cancer. ... survival benefits for B-Raf and Mek inhibitors. Erk ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... a Promising New Flavor Ingredient Achieves ... Collaboration Milestone, SAN ... ), a leading company focused on using proprietary,technologies to discover and ... announced today that it has,received a payment from The Coca-Cola Company ...
... Presentation at 48th ICAAC / IDSA 46th Annual ... Oct. 28 ,Medarex, Inc. (Nasdaq: MEDX ), ... PIP ), a biodefense company developing medical,countermeasures ... a pilot study showing that the anthrax anti-toxin, ...
... QUEBEC CITY, Oct. 28 /PRNewswire-FirstCall/ - AEterna Zentaris ... biopharmaceutical company focused on,endocrine therapy and oncology, today ... Officer, Paul Blake, MD, will present a company,overview ... on,Monday, November 3, 2008 at 8:00 am (Eastern ...
Cached Biology Technology:SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 2SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 3Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 2Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 3Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 4Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 5Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 6Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 7
Mouse Axl MAb (Clone 175128)...
Mouse GDF-8 Propeptide Affinity Purified Polyclonal Ab...
... D. Dawbarn and S.J. Allen (1995) ... date reviews by world authorities on current ... for Alzheimer's disease. Several major advances have ... understanding of this disease. Topics include molecular ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.1 mg/dL to 100 mg/dL. Procedure: 20 min....
Biology Products: